PROTEOMIC ANALYSIS OF HUMAN BLOOD AND URINE IN DIABETIC NEPHROPATHY
Keywords:
Diabetic mellitus, SDS-PAGE, LC-MS, Lipid profile, Diabetic nephropathyAbstract
Objective: To investigate the proteomics status of human blood and urine in diabetic nephropathy.
Methods: In the present study 90 patients were selected. The study was comprised of 30 Diabetic mellitus (DM) with microalbuminuria patients (Group 3), 30 DM without microalbuminuria patients (group 2), 30 healthy controls (Group 1). Fasting glucose, post prandial glucose, lipid profile, fructosamine in serum and micro albumin in urine were investigated in all the patients.
Results: The significant increase in serum fructosamine, fasting and post prandial glucose levels along with increased microalbuminuria observed in group 3 patients compared to group 2 and group 1 patients. Hyperglycemia increases fructosamine, cholesterol, triglycerides with decrease in HDL-cholesterol levels, indicates the major risk of atherogenicity. To study the effect of age, smoking, DM duration on DN, patients were grouped in different way and analysed.
Conclusion: The results suggested that smoking, age and prolonged DM influences DN. Normal and DN patients serum and urine samples were selected and protein was separated by SDS-PAGE and identified by LC-MS. Results of LC-MS showed the difference in proteomics of normal and DN patients.
Downloads
References
Kim SH, Hyun SH, Choung SY. Antidiabetic effect of Cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 2006;104:119-23.
Chatopadhyay RR, Bandyopadhyay M. Effect of Azadirachta indica leaf extract on serum lipid profile changes in normal and Streptozotocin induced diabetic rats. African J Biomed Res 2005;8:101-4.
Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004;92:1-21.
Giunti S, Barit D, Cooper ME. Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med 2006;97:241-62.
José M, González-Buitrago, Laura Ferreira, Isabel Lorenzo. Urinary proteomics. Spain Elsevier 2007. p. 49–56.
Rafael N, Moresco, Manuela B, Sangoi, José AM. De Carvalho, Etiane Tatsch, et al. Bochi, Diabetic nephropathy: Traditional to proteomic markers; 2013. p. 17-30.
Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Cli Biochem 2013;6:24-7.
Lowry OH, Rosenbrough NJ, Farr ALI, Randall RL. Protein measurement with the Folin-phenol reagent. J Bio Chem 1951;193:264-75.
Rothschild M, Oratz M, Schreibner S. Albumin synthesis and albumin degradation. In: Proceedings of the workshop on albumin, Sgouris JT, Rene A, eds; 1975. p. 57–74.
Walton H, Marsh, Benjamin Fingerhut, Henry Muller. Automated and manual direct method for the determination of blood urea 1965;11:6.
Andrew D, Rule MD, Timothy S, Larson MD, Erik J, Bergstralh, et al. Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease; 2004. p. 959-61.
Varely H. Practical Clinical Biochemistry. 4th Edition. CBS Publication. Delhi; 1988. p. 260.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
Fossati P, Prencipe C. Serum triglycerides determined colorimetrically withan enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
Lutz R. Veronika Eichacker. Anal Membr Proteins 2006:310-5.
Shen S, Jing Y, Kuang T. Proteomics approach to identify wound-response related proteins from rice leaf sheath. Proteomics 2003;3(4):527-35.
American Diabetes Association. Diabetes Care 2006. p. 29.
Snehalatha RC, Ramachandran A, Wan Ma C. Diabetes in Asia. Lancet 2010;375(9712):408-18.
MCDonald J. Alcohol and diabetes. Diabetes Care 198;3:629–37.
Durrington PN. Hyperlipidaemia: Diagnosisand Management. 2d ed. Oxford, Great Britain; 2009.
Fagard RH, Nilsson PM. Smoking and diabetes–the double health hazard. Primary Care Diabetes 2005;3:4-9.
Chait A, Mancini M, February AW, Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet 1972;2(7767):62-4.
Castelli WP, Butterworth-Heinemann, Gordon T, Hjortland MC, Kagan A, Doyle JT, et al. Alcohol and blood lipids: The Cooperative Lipoprotein Phenotyping Study; 1997. p. 76-89.
Lin RC, Dai J, Lumeng L, Zhang MOH, Rosenbrough NJ, Farr ALI, et al. Protein measurement with the Folin-phenol reagent. J Bio Chem 1951;193,264-75.
Taskinen MR, Valimaki M, Nikkila EA, Kuusi T, Ehnholm C, YlikahrI R. High density lipoprotein subfractions and prostheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metab 1982;31:1168–74.
Kuusi EA, Taskinen MR, Valimaki M, Nikkila T, Ehnholm C, YlikahrI R. High density lipoprotein subfractions and prostheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metab 1983;35:1178–84.
Svendsen P, Andahl Christiansen JS, Andersen AR. Clinical Physiological and Medicine; 1982.
Rahbar S, Blumenfeldo, Ranney HM. Studies of an unusual Hb in patients with Diabetes mellitus. Biochem Biophys Res Commun 1969;36:836-43.
Nathan DM, Kuenen J, Borg R. Translating the AiC assay into estimated average glucose values. Diabetes care 2008;31:1473-78.
Massi Bennedetti M. Chenging targets in the treatment of type II Diabetes. Curr Med Res Opin 2006;22:Suppl 2;5-13.
Tapp RJ, Tikellis G, Wong TY. Logitudinal association of glucose metabolism with retinopathy results from the Australian Diabetes Obesity and lifestyle. Diabetes care 2008;31:1349-54.
Fagard RH, Nilsson PM. Smoking and diabetes–the double health hazard. Primary Care Diabetes 2009;3(4):2005-9.
Nagaya T, Yoshida H, Takahashi. Heavy smoking raises risk for type 2 diabetes milletus in obese men; but, light smoking reduces the risk in lean men: a follow up study in Japan. Ann Epidemiol 2008;18(2):113-8.
Johns Hopkins Medicine website. The Sol Goldman Pancreatic Cancer Research Center (sic). What are the risk factors for pancreatic cancer Accessed; 2012.
Willi C. Active smoking and the risk of Type 2 diabetes. J Am Med Assoc 2007;298:2654-64.
Lynch SM, Vrieling A, Lubin JH. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 2009;170(4):403-13.
Siwy J, Mullen W, Golovko I, Franke J, Zürbig P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 2011;5:367–74.
Siwy J, Mullen W, Golovko I, Franke J, Zürbig P. Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 2011;5:367–74.
Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH. Matrix etalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 2006;20:1898–900.
Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM. The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics Clin Appl 2008;2:997–1007.
Aronis KN, Kim YB, Mantzoros CS. Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk? Metab 2011;60:747–8.